(3-Oxo-1,3-dihydro-2H-indazol-2-yl)acetic acid
![]() |
- $64 - $464
- Product name: (3-Oxo-1,3-dihydro-2H-indazol-2-yl)acetic acid
- CAS: 64697-24-1
- MF: C9H8N2O3
- MW: 192.17
- EINECS:
- MDL Number:MFCD16171059
- Synonyms:(3-Oxo-1,3-dihydro-2H-indazol-2-yl)acetic acid;2-(3-Oxo-2,3-dihydro-1H-indazol-2-yl)acetic acid;2-(3-OXO-1H-INDAZOL-2(3H)-YL)ACETIC ACID;2H-Indazole-2-acetic acid, 1,3-dihydro-3-oxo-
4 prices
Selected condition:
Brand
- ChemBridge Corporation
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 250mg
- 500mg
- 1g
- ManufacturerChemBridge Corporation
- Product numberBB-4043981
- Product description(3-oxo-1,3-dihydro-2H-indazol-2-yl)aceticacid 95%
- Packaging250mg
- Price$64
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM240782
- Product description2-(3-Oxo-1H-indazol-2(3H)-yl)aceticacid 97%
- Packaging1g
- Price$439
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11080529
- Product description2-(3-Oxo-1H-indazol-2(3H)-yl)aceticacid 97%
- Packaging1g
- Price$464
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number065465
- Product description(3-Oxo-1,3-dihydro-2H-indazol-2-yl)acetic acid
- Packaging500mg
- Price$394
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
ChemBridge Corporation | BB-4043981 | (3-oxo-1,3-dihydro-2H-indazol-2-yl)aceticacid 95% | 250mg | $64 | 2021-12-16 | Buy |
Chemenu | CM240782 | 2-(3-Oxo-1H-indazol-2(3H)-yl)aceticacid 97% | 1g | $439 | 2021-12-16 | Buy |
Crysdot | CD11080529 | 2-(3-Oxo-1H-indazol-2(3H)-yl)aceticacid 97% | 1g | $464 | 2021-12-16 | Buy |
Matrix Scientific | 065465 | (3-Oxo-1,3-dihydro-2H-indazol-2-yl)acetic acid | 500mg | $394 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|